BSX Boston Scientific
$42.19 -0.50%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
-0.50%
YTD
-56.00%
P/E
16.93
P/B
5.83
ROE
14.9%
Div yield
—
Beta
0.19
Market cap
$62.2B
RSI (14)
34
Next earnings
Oct 28, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$42.47
Close
$42.19
VWAP (n/a)
—
Day high
$42.75
Day low
$42.00
Volume
12.5M
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
Stryker (SYK) vs Boston Scientific (BSX): Which is a Better Stock to Buy?
Yahoo Finance · Oct 7
Boston Scientific (BSX) Stock Sinks As Market Gains: What You Should Know
Yahoo Finance · Oct 2
Elutia Receives $8 Million Payment from Boston Scientific; Company Now Fully Funded into 2029
Yahoo Finance · Oct 1
Cyted Health appoints Thomas West as Board Chair and Robert Epstein as Non-Executive Director to drive US growth
Yahoo Finance · Sep 29
How Big Could BSX Stock's Next Fall Be?
Yahoo Finance · Sep 28
Why Oppenheimer Cut Boston Scientific’s Price Target by $20 Despite Keeping its Outperform Rating
Yahoo Finance · Sep 28
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
8-K Sep 23, 2026 View → 8-K Sep 8, 2026 View → 8-K Aug 26, 2026 View → 10-Q Aug 3, 2026 View → 8-K Jul 29, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell BSX. Try it in the Lab to size a position and see the risk.